Literature DB >> 21272926

Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin.

Yoichi Kobayashi1, Ken-Ichiro Seino, Shinji Hosonuma, Tatsuru Ohara, Hiroaki Itamochi, Seiji Isonishi, Tsunekazu Kita, Haruka Wada, Satoshi Kojo, Kazushige Kiguchi.   

Abstract

OBJECTIVES: In recent years, cancer stem cells (CSCs) have been reported to be correlated with chemoresistance and may also be enriched in side populations (SPs). In this study, the relationship between resistance to paclitaxel (PTX) and cisplatin (CDDP) and side populations was examined in three parental PTX- and CDDP-sensitive ovarian cancer cell lines (2008, KF28, and TU-OM-1) and several other cell lines derived from these as well as the additional effects of interferon-alpha (INF-α).
METHODS: SP of three different parental cell lines and PTX- and/or CDDP-resistant cell lines derived from these was analyzed with flow cytometry. The expression of ABCB1 and ABCG2 in KF28 and its derived cell lines was examined. Additional cell-death effect of INF-α with PTX was also examined.
RESULTS: In the three parental cell lines and the PTX-sensitive cell lines derived from these lines, SP was very low. Conversely, in PTX-resistant cell lines, regardless of CDDP resistance, SP increased. ABCB1 was strongly expressed in the PTX-resistant cells, but not in their parental lines, which are sensitive to PTX. While INF-α showed only slight enhancement of the cell-death effect of PTX in PTX-sensitive cells, INF-α itself strongly induced apoptosis in PTX-resistant cells regardless of PTX concentration.
CONCLUSIONS: The SP could be correlated with resistance to PTX. SP could be a target of INF-α, and resistance to PTX might be overcome by INF-α.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272926     DOI: 10.1016/j.ygyno.2010.12.366

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  26 in total

1.  The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthase.

Authors:  Kaustubh N Bhinge; Vineet Gupta; Salman B Hosain; Seetharama D Satyanarayanajois; Sharon A Meyer; Benny Blaylock; Qian-Jin Zhang; Yong-Yu Liu
Journal:  Int J Biochem Cell Biol       Date:  2012-06-19       Impact factor: 5.085

Review 2.  Interferons as inducers of apoptosis in malignant cells.

Authors:  Kevin P Kotredes; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

3.  Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells.

Authors:  Kyoko Tanaka; Kazushige Kiguchi; Mikio Mikami; Daisuke Aoki; Masao Iwamori
Journal:  Hum Cell       Date:  2019-07-26       Impact factor: 4.174

Review 4.  Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma.

Authors:  Xiaoxiang Chen; Jing Zhang; Zhihong Zhang; Hongxia Li; Wenjun Cheng; Jinsong Liu
Journal:  Hum Pathol       Date:  2013-07-11       Impact factor: 3.466

Review 5.  Ovarian cancer stem cells: elusive targets for chemotherapy.

Authors:  Achuta Kumar Guddati
Journal:  Med Oncol       Date:  2012-05-26       Impact factor: 3.064

Review 6.  Ovarian cancer stem cells: are they real and why are they important?

Authors:  Monjri M Shah; Charles N Landen
Journal:  Gynecol Oncol       Date:  2013-12-07       Impact factor: 5.482

7.  Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.

Authors:  Rachel Eyre; Ian Harvey; Katherine Stemke-Hale; Thomas W J Lennard; Alison Tyson-Capper; Annette P Meeson
Journal:  Tumour Biol       Date:  2014-07-04

Review 8.  Therapeutic strategies targeting cancer stem cells.

Authors:  Xiaoyan Ning; Jianchang Shu; Yiqi Du; Qiwen Ben; Zhaoshen Li
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

9.  Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy.

Authors:  Shyam A Patel; Shakti H Ramkissoon; Margarette Bryan; Lillian F Pliner; Gabriela Dontu; Prem S Patel; Sohrab Amiri; Sharon R Pine; Pranela Rameshwar
Journal:  Sci Rep       Date:  2012-11-30       Impact factor: 4.379

10.  Isolation and characterization of side population cells from the human ovarian cancer cell line SK-OV-3.

Authors:  Zhengyi Ruan; Jianhua Liu; Yanping Kuang
Journal:  Exp Ther Med       Date:  2015-10-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.